These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2294370)

  • 1. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
    Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
    Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
    Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
    Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats.
    Moritomo Y; Hirano T; Ebara T; Kurokawa M; Naito H; Furukawa S; Nagano S
    Nephron; 1994; 67(2):218-25. PubMed ID: 8072613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
    Ćwiklińska A; Cackowska M; Wieczorek E; Król E; Kowalski R; Kuchta A; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Zielińska J; Dębska-Ślizień A; Jankowski M
    Kidney Blood Press Res; 2018; 43(3):970-978. PubMed ID: 29913451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism.
    Mamo JC; Hirano T; James L; Szeto L; Steiner G
    Metabolism; 1991 Sep; 40(9):888-93. PubMed ID: 1895953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor.
    Yoshino G; Hirano T; Nagata K; Maeda E; Naka Y; Murata Y; Kazumi T; Kasuga M
    J Lipid Res; 1993 Jun; 34(6):875-84. PubMed ID: 8354953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
    Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
    Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of hypertriglyceridemia in Dahl salt-sensitive rats, an animal model of spontaneous nephrotic syndrome.
    Hirano T; Ebara T; Furukawa S; Nagano S; Takahashi T
    Metabolism; 1994 Feb; 43(2):248-56. PubMed ID: 8121310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin.
    Levy E; Ziv E; Bar-On H; Shafrir E
    Biochim Biophys Acta; 1990 Apr; 1043(3):259-66. PubMed ID: 2322571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen effects on triglyceride metabolism in analbuminemic rats.
    Shearer GC; Joles JA; Jones H; Walzem RL; Kaysen GA
    Kidney Int; 2000 Jun; 57(6):2268-74. PubMed ID: 10844597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of lipoprotein lipase in experimental nephrosis.
    Liang K; Vaziri ND
    J Lab Clin Med; 1997 Oct; 130(4):387-94. PubMed ID: 9358077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL.
    Shearer GC; Couser WG; Kaysen GA
    Kidney Int; 2004 Jan; 65(1):228-37. PubMed ID: 14675054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascites fluid lipoproteins in experimental nephrotic syndrome.
    Garber DW; Marsh JB
    Biochim Biophys Acta; 1988 Apr; 959(3):253-61. PubMed ID: 3355849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of hypertriglyceridemia in the genetically obese Zucker rat.
    Wang CS; Fukuda N; Ontko JA
    J Lipid Res; 1984 Jun; 25(6):571-9. PubMed ID: 6747461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
    Shearer GC; Kaysen GA
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.